CDC’s Investments to Combat Antibiotic Resistance Threats: AR & COVID-19 Funding Help: Stop Spread of Emerging Threats: Fiscal Year 2021 Sampling of Shared Activities

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Fiscal Year 2021 Sampling of Shared Activities
  
  Many of the nation’s efforts to prevent the spread of SARS-CoV-2 will also help in the fight against antibiotic resistance, including investments in infection control and prevention (IPC), training, surveillance, and public health personnel. The following represent many of those shared public health activities that CDC led in Fiscal Year 2021 using appropriations for AR or COVID-19.
  
  Publication date from document properties.
  
  ARfundingHelpsCovid.pdf
  
  
• Subjects:
  Antimicrobial Stewardship Carbapenem-Resistant Enterobacteriaceae Communicable Diseases, Emerging Coronavirus Infections COVID-19 Cross Infection/prevention & Control Drug Resistance, Microbial Financing, Government Food Safety Local Government Pandemics Public Health State Government

  More +
• Series:
  Antibiotic Resistance (AR) Solutions in Action
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  United States
• Pages in Document:
  6 numbered pages
• Federal Fiscal Year:
  2021
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:0c112b017a4264d32ac24f048d26d1c20be577b832a028a9b77156526bddf741391f3dc10b90a2ff4d302b630f6620e25c3573fcb0a41189d95ca5868d1dc5db
• Download URL:
  https://stacks.cdc.gov/view/cdc/116910/cdc_116910_DS1.pdf
• File Type:
  [PDF - 2.28 MB ]